Click

Below is a selected list of timely federal funding opportunities that are relevant to the osteopathic medical education community. AACOM updates this resource frequently.  Please bookmark the page for your reference. For a comprehensive listing of federal funding opportunities, please visit Grants.gov.   

Featured Opportunities

May 17 – May 23

Agency for Healthcare Research and Quality

AHRQ Small Research Grant Program (R03)

Application Due: June 16, 2018; October 16, 2018, by 5:00 PM local time of applicant organization

The R03 grant mechanism supports different types of health services research projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology.

AHRQ Health Services Research Projects (R01)

Application Due: June 5, 2018; October 5, 2018, by 5:00 PM local time of applicant organization

The Research Project Grant (R01) is an award made by AHRQ to an institution/organization to support a discrete, specified health services research project. The R01 research plan proposed by the applicant institution/organization must be related to the mission and priority research interests of AHRQ.

AHRQ Health Services Research Demonstration and Dissemination Grants (R18)

Application Due: September 25, 2018, by 5:00 PM local time of applicant organization

The Research Demonstration and Dissemination Grant (R18) is an award made by AHRQ to an institution/organization to support a discrete, specified health services research project. The R18 proposed research plan must be related to the mission and priority research interests of AHRQ.

National Institutes of Health

Collaborative Network to Advance Deprescribing Research for Older Adults with Multiple Chronic Conditions (R24 Clinical Trial Optional)

Letter of Intent Due: September 18, 2018

Application Due: October 18, 2018, by 5:00 PM local time of applicant organization

This opportunity will support a collaborative network to advance scientific research into techniques and outcomes of deprescribing medications for prevention and treatment of older adults with multiple chronic conditions.

Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 - Clinical Trial Not Allowed)

Letter of Intent Due: 30 days prior to the application due date

Application Due: August 9, 2018, by 5:00 PM local time of applicant organization

This opportunity will address the needs of the maternal and pediatric HIV scientific community for research data translation and sharing. This initiative will support secondary data analyses using archived HIV/AIDS data and specimens to generate new research questions and findings.


May 10 – May 16

National Institutes of Health

Development and Testing of Novel Interventions to Improve HIV Prevention, Care, and Program Implementation (R34-Clinical Trial Optional)

Application Due: September 7, 2018, by 5:00 PM local time of applicant organization

This opportunity is for formative research, intervention development, and pilot-testing of interventions. Primary scientific areas of focus include the feasibility, tolerability, acceptability and safety of novel or adapted interventions that target HIV prevention, treatment or services research.

NINDS Research Education Opportunities (R25 Clinical Trial Not Allowed)

Letter of Intent Due: 30 days prior to application due date

Application Due: August 27, 2018, by 5:00 PM local time of applicant organization

The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH.  The over-arching goal of this program is to support educational activities that complement and/or enhance the training of a workforce to meet the nation's biomedical, behavioral and clinical research needs.

Centers for Disease Control

Racial and Ethnic Approaches to Community Health (REACH)

Application Due: July 16, 2018

This 5-year initiative is to improve health, prevent chronic diseases, and reduce health disparities among racial and ethnic populations with the highest risk, or burden, of chronic disease.